Yüklüyor......
An updated review of the treatment landscape for advanced gastrointestinal stromal tumors
Before the introduction of tyrosine kinase inhibitors (TKIs), the overall survival of patients with advanced or metastatic gastrointestinal stromal tumors (GISTs) was 10 to 20 months because of the lack of approved therapies. In the last 20 years, a treatment algorithm for patients with advanced GIS...
Kaydedildi:
| Yayımlandı: | Cancer |
|---|---|
| Asıl Yazarlar: | , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
John Wiley and Sons Inc.
2021
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8252111/ https://ncbi.nlm.nih.gov/pubmed/33974733 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cncr.33630 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|